A Safety, Efficacy and Systemic Exposure Study of CD5789 Cream in Adults and Adolescents With Lamellar Ichthyosis
Condition: Lamellar Ichthyosis Interventions: Drug: CD5789 Cream 200 µg/g; Drug: CD5789 Cream 100 µg/g; Drug: CD5789 Cream Vehicle Sponsor: Mayne Pharma International Pty Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 12, 2018 Category: Research Source Type: clinical trials